Filing Details

Accession Number:
0001140361-16-073485
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-07-27 13:01:26
Reporting Period:
2016-07-25
Filing Date:
2016-07-27
Accepted Time:
2016-07-27 13:01:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1335103 Protea Biosciences Group Inc. PRGB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529510 C Stephen Turner 1311 Pineview Drive
Suite 501
Morgantown WV 26505
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-07-25 20,000 $0.15 2,197,372 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1462 to $0.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote 1 to this Form 4.